THNR

Amplify$24.26-0.44 (-1.78%)
AUM $5.0MER 0.59%NAV $25.04Holdings 20

Price Chart

Key Statistics

Previous Close

$24.70

Day Range

$24.26$24.71

52-Week Range

$23.48$27.91

Avg Volume

961

Dividend Yield

1.67%

Expense Ratio

0.59%

AUM

$5.0M

Shares Outstanding

200.0K

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States56.60%
Denmark12.28%
China11.14%
United Kingdom5.84%
Switzerland5.72%
Japan5.21%
South Korea3.21%

Fund Information

Issuer
Amplify
Category
Healthcare
Inception Date
May 20, 2024
Exchange
NYSE_ARCA
Description
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$46.92B
VHTVanguard Health Care ETF$20.80B
VTWOVanguard Russell 2000 ETF$16.80B
RWLInvesco S&P 500 Revenue ETF$10.01B
XBIState Street SPDR S&P Biotech ETF$9.64B

The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund issued by Amplify that launched on May 20, 2024. It currently manages $5.0M in assets under management. The fund charges an expense ratio of 0.59%. The fund holds 20 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 67.0% of the fund

RankSymbolNameWeight %SharesMarket Value
1LLYEli Lilly & Co11.94%437$590K
2NVONovo Nordisk A/S8.75%11,139$433K
3REGNRegeneron Pharmaceuticals Inc6.15%330$304K
4AMGNAmgen Inc6.03%684$298K
5GILDGilead Sciences Inc5.91%1,756$292K
6ROP.SWRoche Holding AG5.87%613$290K
7AZNAstraZeneca PLC5.81%1,638$287K
8ABBVAbbVie Inc5.72%998$283K
94519.TChugai Pharmaceutical Co Ltd5.52%6,000$273K
10PFEPfizer Inc5.27%9,456$260K
111093.HKCSPC Pharmaceutical Group Ltd4.83%226,000$239K
12MRKMerck & Co Inc4.72%1,757$233K
131801.HKInnovent Biologics Inc4.63%21,000$229K
14VKTXViking Therapeutics Inc4.13%7,911$204K
15128940.KSHanmi Pharm Co Ltd3.06%477$151K

Detailed Returns

PeriodReturnETF
1D
-1.78%
1W
-5.84%
1M
-1.78%
3M
-11.94%
6M
-1.48%
YTD
-4.57%
1Y
-4.60%
3Y
-4.49%
5Y
-4.49%

Moving Averages

20-Day MA

$25.56

Below 20-Day MA
50-Day MA

$25.22

Below 50-Day MA
200-Day MA

$25.30

Below 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$27.91

Current Price

$24.26

52-Week Low

$23.48

$23.48$27.91

Current Yield

1.67%

Annual Dividend

$1.2661

Frequency

1x/year

Last Ex-Date

Dec 30, 2025

Dividend History

Ex-DateAmountPay Date
Dec 30, 2025$0.4132Dec 31, 2025
Dec 30, 2025$0.4132Dec 31, 2025
Dec 30, 2024$0.2199Dec 31, 2024
Dec 30, 2024$0.2199Dec 31, 2024

Dividend Payments Over Time

Category Comparison

MetricTHNRHealthcare(212 ETFs)Healthcare(24 ETFs)
Fund Info
Expense Ratio0.59%0.68%0.47%
AUM$5.0M$842.0M$840.0M
Dividend Yield1.67%5.54%1.58%
Avg Volume961257.4K176.4K
Holdings20124172
Performance
1-Month Return-2.77%-7.05%-3.70%
6-Month Return+1.13%-1.75%+4.92%
YTD Return-3.81%+2.72%+5.77%
1-Year Return-6.59%+0.26%+4.66%

Compare with Another ETF

Search for an ETF to compare with THNR:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.